Skip to main content

Day: April 16, 2025

Treasure Global Inc. Secures Exclusive Rights to Launch Mezzofy’s USD40 Billion Coupon Platform in Malaysia

Scalable Rollout Targets USD2 to 4 Million in Recurring Annual Revenue Within First Year KUALA LUMPUR, Malaysia, April 16, 2025 (GLOBE NEWSWIRE) — Treasure Global Inc. (NASDAQ: TGL) (“Treasure Global” or the “Company”), is pleased to announce an exclusive strategic partnership with Mezzofy (Hong Kong) Limited (“Mezzofy”), a market leader in digital coupon management solutions. Under this agreement, Treasure Global becomes the sole distributor of Mezzofy’s platform in Malaysia, positioning the Company to capture approximately USD2 to 4 million in recurring annual revenue within the first 12 months of rollout. Since its inception, Mezzofy’s cloud-based “Coupon-as-a-Service” (CaaS) platform has facilitated over USD40 billion in digital coupon transactions across 15 markets (as of 2024), serving high-profile merchants including Coffee...

Continue reading

Oncotelic Therapeutics Reports FY 2024 Highlights and FY 2024 Earnings Compared to FY 2023 

AGOURA HILLS, Calif., April 16, 2025 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc (OTCQB:OTLC) (“Oncotelic”, the “Company” or “We”), a developer of treatments for rare and orphan indications, including Parkinson’s Disease, pancreatic ductal adenocarcinoma (“PDAC”), diffuse intrinsic pontine glioma (“DIPG”), and various other cancers, today announced its financial results for the fiscal year ended December 31, 2024 (“FY 2024”), as compared to the fiscal year ended December 31, 2023 (“FY 2023”). The financial results are based on the Annual Report on Form 10-K (“Form 10-K”) as filed with the Securities and Exchange Commission (“SEC”) on April 15, 2025. Highlights for FY 2024 and thereafter: 2024 has been a transformational year for us. We made great progress on multiple fronts and this...

Continue reading

SUNation Energy Announces Reverse Stock Split

RONKONKOMA, N.Y., April 16, 2025 (GLOBE NEWSWIRE) — SUNation Energy, Inc. (Nasdaq: SUNE) (“SUNation” or “the Company”), a leading provider of sustainable solar energy and backup power solutions for households, businesses, and municipalities, today announced that its Board of Directors approved a 200 – for 1 reverse stock split of the Company’s outstanding common stock effective 12:01 a.m. Eastern Time on April 21, 2025. The Company’s common stock will continue to trade under the symbol “SUNE” and it is expected to open for trading on Nasdaq on April 21, 2025 on a post-split basis. The new CUSIP number for the common stock following the reverse stock split will be 72303P503. The ratio of the reverse stock split is within the range approved by shareholders at a Special Meeting of Shareholders held on April 3, 2025. The reverse...

Continue reading

ScanTech AI Systems to Unveil its CustomsTrace AI™ to Pioneer Goods Verification in a Shifting Tariff Landscape

A Forward-Looking Platform Designed to Empower Customs with AI-Driven Goods Identification and Trade ComplianceScan Tech LogoScan Tech LogoAtlanta, GA, April 16, 2025 (GLOBE NEWSWIRE) — ScanTech AI Systems Inc. (the “Company” or “ScanTech AI”) (Nasdaq: STAI),  a global innovator in non-intrusive, fixed-gantry CT (Computed Tomography) screening technologies, today announced the initial development of its CustomsTrace AI™ platform, a groundbreaking initiative aimed at addressing what is anticipated to be one of the most pressing challenges in today’s global trade environment, accurate identification and verification of tariff-sensitive goods at national borders including the prevention of unauthorized or illicit importation of restricted items. As tariff regulations and international trade policies continue to shift,...

Continue reading

Veeco Announces Date for First Quarter Financial Results and Conference Call

PLAINVIEW, N.Y., April 16, 2025 (GLOBE NEWSWIRE) — Veeco Instruments Inc. (NASDAQ: VECO) plans to release its first quarter 2025 financial results after the market closes on Wednesday, May 7, 2025. The company will host a conference call to review these results starting at 5:00 PM ET that day. To join the call, dial 1-877-407-8029 (toll free) or 1-201-689-8029. Participants may also access a live webcast of the call by visiting the investor relations section of Veeco’s website at ir.veeco.com. A replay of the webcast will be made available on the Veeco website beginning at 8:00 PM ET that same evening. About Veeco Veeco (NASDAQ: VECO) is an innovative manufacturer of semiconductor process equipment. Our laser annealing, ion beam, single wafer etch & clean, lithography, metal organic chemical vapor deposition (MOCVD),...

Continue reading

Clinton Health Access Initiative and OneSight EssilorLuxottica Foundation Launch Strategic Partnership to Expand Vision Care Access Across Africa

KIGALI, Rwanda, April 16, 2025 (GLOBE NEWSWIRE) — The Clinton Health Access Initiative (CHAI) and the OneSight EssilorLuxottica Foundation have announced a multi-year partnership to advance access to eyeglasses and build sustainable vision care systems across Africa. With a shared focus on health equity, the collaboration aims to address one of the continent’s most widespread yet neglected public health challenges: uncorrected poor vision. In sub-Saharan Africa, an estimated 12.6 percent of the population lives with some form of refractive error, with 3.4 percent experiencing visual impairment due to uncorrected refractive error.¹ This silent barrier limits children’s ability to learn, adults’ ability to work, and older persons’ ability to live independently, often pushing entire families deeper into cycles of poverty. Yet, with...

Continue reading

Sonnet Releases Virtual Investor “What This Means” Segment

– Raghu Rao, Interim Chief Executive Officer and Dr. Richard Kenney, Chief Medical Officer, of Sonnet discuss the recently announced safety data related to SON-1010 – Watch the “What This Means” video here PRINCETON, N.J., April 16, 2025 (GLOBE NEWSWIRE) — Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the “Company” or “Sonnet”), a clinical-stage company developing immunotherapeutic drugs targeted to the tumor microenvironment (TME), today announced that members of the Sonnet management team participated in a Virtual Investor “What This Means” segment. As part of the segment, Raghu Rao, Interim Chief Executive Officer and Dr. Richard Kenney, Chief Medical Officer, discussed the recently announced positive safety results of SON-1010 (IL12-FHAB) at the highest dose...

Continue reading

DSV – Q1 2025 results and expected completion of Schenker acquisition analyst conference call

We expect to complete the announced acquisition of Schenker and release the Q1 2025 interim results of DSV A/S on 30 April 2025. A conference call is scheduled for 11:30 am CEST. At the conference call, Jens H. Lund, Group CEO, and Michael Ebbe, Group CFO, will present the Q1 2025 Interim Financial Report as well as further details and preliminary financial information related to the acquisition of Schenker. The presentation will be followed by a Q&A session. Date:                 30 April 2025Time:                 11:30 am CEST To attend the webcast presentation, please go to Webcast presentation – DSV Interim Financial Report Q1 2025 or to https://investor.dsv.com/. If you wish to ask questions during the conference call, please register through this link: Conference call Q&A – DSV Interim Financial Report Q1 2025....

Continue reading

Goosehead Insurance, Inc. to Report First Quarter 2025 Results

WESTLAKE, Texas, April 16, 2025 (GLOBE NEWSWIRE) — Goosehead Insurance, Inc. (“Goosehead” or the “Company”) (NASDAQ: GSHD) announced today that it will report its first quarter 2025 results after the market close on Wednesday, April 23, 2025. The company will hold a conference call to discuss results at 4:30 PM ET on April 23rd. To access the call by phone, participants should go to this link (registration link), and you will be provided with the dial in details. A live webcast of the conference call will also be available on Goosehead’s investor relations website at ir.gooseheadinsurance.com. A webcast replay of the call will be available at ir.gooseheadinsurance.com for one year following the call. About Goosehead Goosehead (NASDAQ: GSHD) is a rapidly growing and innovative independent personal lines insurance agency that distributes...

Continue reading

Progyny to Host Events Honoring Individuals, Families and Infertility Throughout National Infertility Awareness Week® and Canadian Fertility Awareness Week®

As awareness around the need for expanded access and coverage of fertility grows, Progyny lifts off the conversation and provides a platform for the millions of individuals facing family building challenges NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) — Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced a series of events to commemorate National Infertility Awareness Week (NIAW) and Canadian Fertility Awareness Week (CFAW), both recognized from April 20-26, 2025. At the heart of the events is the company’s mission to educate and empower more women and families in achieving their family building goals, with longtime Progyny partner and industry leader RESOLVE: The National Infertility Association lending its voice to the programming for NIAW, and Fertility Matters Canada for...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.